R. Ross

Pharmacology · Pharmacological Reviews · 2002–2015

A researcher in the Science corpus: 4 papers; trusts 6 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom R. Ross trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Pertwee
  2. S. Jordt
  3. A. Kreitzer
  4. B. Cravatt
  5. D. Julius
  6. Wade G. Regehr
  7. H. Chuang

Who trusts R. Ross overall

  1. R. Pertwee
  2. I. S. Ramsey

Papers from R. Ross's perspective

Ordered by how strongly the researchers R. Ross trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) (British Journal of Pharmacology)
  2. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1 (Nature)
  3. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. (Neuron)
  4. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. (Proceedings of the National Academy of Sciences of the United States of America)
  5. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide (British Journal of Pharmacology)
  6. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. (Neuron)
  7. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro (British Journal of Pharmacology)
  8. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. (Brain Research)
  9. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
  10. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (Proceedings of the National Academy of Sciences of the United States of America)

Their papers